No Data
No Data
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
Lantern Pharma to Host & Participate in Two Public Webinars During October
Express News | Lantern Pharma Inc - Phase 1B/2a Trial for Recurrent GBM to Start Late 2024
Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA
Express News | Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA
Lantern Pharma Inc (LTRN) Q2 2024 Earnings Call Highlights: Promising Clinical Trials and ...
jimmy the trader : $China Pharma (CPHI.US)$ broths